Randall Kaye serves as Executive at AVANIR PHARMACEUTICALS, where they oversee executive responsibilities. Since joining the company, Randall Kaye has executed 53 insider transactions totaling $1.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 26, 2006 involved purchasing 50 shares valued at $495.
Randall Kaye currently holds 21,020 shares of AVANIR PHARMACEUTICALS (AVNR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Randall Kaye has been a net seller of AVNR stock. They have purchased $45.4K and sold $1.9M worth of shares.
Randall Kaye's most recent insider trade was on May 26, 2006, when they purchased 50 shares at $9.89 per share.
Get notified when new Form 4 filings are submitted
| $9.90 |
| Discretionary |
| May 8, 2006 | AVNR | $500 | Option Exercise | 12,500 | $0.04 | Discretionary |